To view this email as a web page, click here.
April 30, 2018
 
Psoriasis Practice Essentials
 
Better as one unit: Psoriasis topicals
The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, shows a study published in the Journal of the American Academy of Dermatology.
 
Controlling psoriasis symptoms eludes these patients
Optimal management of psoriasis symptoms falls short for about three in 10 patients with moderate plaque psoriasis and one in five with severe psoriasis, a study shows.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.